Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Aatke van den Maas
The Combined Use of Disease Activity and Infliximab Serum Trough Concentrations for Early Prediction of (Non-)Response to Infliximab in Rheumatoid Arthritis
British Journal of Clinical Pharmacology
Pharmacology
Related publications
Infliximab in Active Early Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Independent Candidate Serum Protein Biomarkers of Response to Adalimumab and to Infliximab in Rheumatoid Arthritis: An Exploratory Study
PLoS ONE
Multidisciplinary
Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy
Clinical Gastroenterology and Hepatology
Hepatology
Gastroenterology
Fibroblast-Like Synovial Cells in Rheumatoid Arthritis- Impact of Infliximab on Hexosoaminidase Activity
Advances in Clinical and Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Clinical and Radiological Efficacy of Infliximab in the Treatment of Rheumatoid Arthritis
Temporal Dissociation Between Disease Activity Reduction and Improvements in Fatigue and Physical Function After Infliximab in Rheumatoid Arthritis
Rheumatology: Current Research
Subtherapeutic Concentrations of Infliximab and Adalimumab Are Associated With Increased Disease Activity in Crohn’s Disease
Therapeutic Advances in Gastroenterology
Gastroenterology
Editorial: Infliximab Trough Cut-Off for Perianal Crohn's Disease - Another Piece of the Therapeutic Drug Monitoring-Guided Infliximab Dosing Puzzle
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Efficacy of Infliximab in Rheumatoid Arthritis: A Relationship to the Total Dose of the Drug
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
